United States · Delivery startup
United States · Spyglass Pharma
Spyglass Pharma provides medicine for ophthalmic diseases.
Funding reportedLast round: Series C
What company datasets say Spyglass Pharma raised
Funding, as reported
Reported in all$110Min dollars
Rounds3
Last roundSeries C
Last round dateJul 2023
Investors listed5
Founders and team
From Spyglass Pharma's own website: 11 on the team.
- Patrick MooneyChief Executive Officer
- Laurie MellottVice President, Clinical Operations
- Mike PinderVice President, Marketing
- Nina NguyenSenior Vice President, Regulatory & Quality
- Paul YooSenior Vice President, Clinical Development
- James DennewillChief Operating Officer
- Jean-Frédéric ViretChief Financial Officer
- Elizabeth O’FarrellBoard Director
- Geoff PardoBoard Director, Gilde Healthcare US
- Habib J. DableBoard Director
- SkyVision CentersBoard Advisors
AdvisersAziz MottiwalaDavid Van Meter
Delivery in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Spyglass Pharma in front of investors. Or tell us what we have wrong.